Immunovia (STO: IMMNOV), the pancreatic cancer diagnostics company, today announces the successful completion of the CLARITI study, (Clinical Validation of Next-Generation Test for Early-Stage ...
Merus’ Bizengri receives US FDA approval to treat pancreatic adenocarcinoma or non–small cell lung cancer: Utrecht, The Netherlands Friday, December 6, 2024, 15:30 Hrs [IST] M ...